prof. dr. apr. Niek Sanders
- Work address
-
Heidestraat 19
9820 Merelbeke - Niek.Sanders@UGent.be
- ORCID iD
-
0000-0003-4585-0343
Show
Sort by
-
Visible Light Conjugation with Triazolinediones as a Route to Degradable Poly(ethylene glycol)-Lipids for mRNA Lipid Nanoparticle Formulation
-
Previous and current efforts to develop a mucosal vaccine against periodontal disease : are we close yet?
-
Chitin immunomodulation stimulates anti-PD-1 therapy in an intraductal model for triple-negative breast cancer
-
Molecular therapies and vaccines face the challenges of emerging infectious diseases
-
- Journal Article
- A1
- open access
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity
-
- Journal Article
- A1
- open access
Choroid plexus-derived extracellular vesicles exhibit brain targeting characteristics
-
- Journal Article
- A1
- open access
A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs
-
Mucosal vaccination against periodontal disease : unexploited potential for veterinary and human oral medicine
-
- Journal Article
- A1
- open access
One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer
-
One cisplatin dose suffices to maintain anti-tumor immunity and enhances anti-PD-1 efficacy in an intraductal model for triple-negative breast cancer